PAPER Feld M, Krawczyk MC, Sol Fustiñana M, Blake MG, Baratti CM, Romano A, Boccia MM
SEARCH RESULTS
330006 RESULTS
PAPER Pláteník J, Fišar Z, Buchal R, Jirák R, Kitzlerová E, Zvěřová M, Raboch J
GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:83-93. Epub 2013 Dec 12 PubMed: 24334212PAPER Forest A, Barrou Z, Verny M
[Neurosyphilis and cognitive disorders].
Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(4):423-31. PubMed: 24333822PAPER Delphin-Combe F, Martin-Gaujard G, Roubaud C, Fortin ME, Husson F, Rouch I, Krolak-Salmon P
[Experience of a care pathway for psychological and behavioral symptoms of dementia].
Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(4):416-22. PubMed: 24333821PAPER Bana L, Minniti S, Salvati E, Sesana S, Zambelli V, Cagnotto A, Orlando A, Cazzaniga E, Zwart R, Scheper W, Masserini M, Re F
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease.
Nanomedicine. 2013 Dec 10; PubMed: 24333591PAPER Kim BH, Lyubchenko YL
Nanoprobing of misfolding and interactions of amyloid β 42 protein.
Nanomedicine. 2014 May;10(4):871-8. Epub 2013 Dec 10 PubMed: 24333588PAPER Marksteiner J, Imarhiagbe D, Defrancesco M, Deisenhammer EA, Kemmler G, Humpel C
Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.
Exp Gerontol. 2014 Feb;50:114-21. Epub 2013 Dec 10 PubMed: 24333505PAPER Alagiakrishnan K, Sankaralingam S, Ghosh M, Mereu L, Senior P
Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
Discov Med. 2013 Dec;16(90):277-86. PubMed: 24333407PAPER Michael R, Otto C, Lenferink A, Gelpi E, Montenegro GA, Rosandić J, Tresserra F, Barraquer RI, Vrensen GF
Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study.
Exp Eye Res. 2014 Feb;119:44-53. Epub 2013 Dec 12 PubMed: 24333259PAPER Cochran JN, Hall AM, Roberson ED
The dendritic hypothesis for Alzheimer's disease pathophysiology.
Brain Res Bull. 2014 Apr;103:18-28. Epub 2013 Dec 12 PubMed: 24333192PAPER Lee DR, McKeith I, Mosimann U, Ghosh-Nodial A, Grayson L, Wilson B, Thomas AJ
The Dementia Cognitive Fluctuation Scale, a New Psychometric Test for Clinicians to Identify Cognitive Fluctuations in People with Dementia.
Am J Geriatr Psychiatry. 2013 Dec 12; PubMed: 24332982PAPER Hong YJ, Yoon B, Shim YS, Han IW, Han SH, Park KH, Choi SH, Ku BD, Yang DW
Do Alzheimer's disease (AD) and subcortical ischemic vascular dementia (SIVD) progress differently?
Arch Gerontol Geriatr. 2014 May-Jun;58(3):415-9. Epub 2013 Nov 22 PubMed: 24332770PAPER Wang JZ, Zhu WD, Xu ZX, Du WT, Zhang HY, Sun XW, Wang XH
Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
Med Hypotheses. 2014 Feb;82(2):145-50. Epub 2013 Nov 28 PubMed: 24332564PAPER Huang XT, Qian ZM, He X, Gong Q, Wu KC, Jiang LR, Lu LN, Zhu ZJ, Zhang HY, Yung WH, Ke Y
Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
Neurobiol Aging. 2014 May;35(5):1045-54. Epub 2013 Nov 13 PubMed: 24332448PAPER Reiman EM
Alzheimer's disease and other dementias: advances in 2013.
Lancet Neurol. 2014 Jan;13(1):3-5. PubMed: 24331781Current Filters
No filters selected